pimethixene

This page covers all pimethixene drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2A, Histone-lysine N-methyltransferase SETD7, Transcriptional activator protein luxR.

Targets

5-hydroxytryptamine receptor 2A, Histone-lysine N-methyltransferase SETD7, Transcriptional activator protein luxR

Phase 2 pipeline (1)

• Calmixen · Other
  Calmixen works by inhibiting the activity of Histone-lysine N-methyltransferase SETD7, an enzyme involved in gene regulation.

Patent intelligence

• pimethixene patent landscape — aggregated cliff calendar, attackable patents, originator estates